Analyst firms · Wedbush · CRI
Wedbush CRI price target and rating history
Carter's Inc. (CRI) · Consumer Discretionary
Wedbush rates Carter's Inc. (CRI) Neutral with a $78 price target, as of its latest action on Jan 26, 2023. It has published 3 rating actions on CRI since October 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a CRI price target in the last 12 months, the median target is $42.
- Current rating
- Neutral
- Price target
- $78
- Median target, all firms
- $42
- Actions on CRI
- 3
Wedbush price target on CRI
Every Wedbush rating on CRI
- Jan 26, 2023
- Mar 7, 2022
- Oct 5, 2021
How other firms rate CRI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $40 | Sep 9, 2026 |
| Wells Fargo | Equal Weight | $42 | Jun 17, 2026 |
| Monness, Crespi, Hardt | Buy | $50 | May 7, 2026 |
| Goldman Sachs | Buy | $38 | Apr 9, 2026 |
| Needham | Hold | Mar 26, 2026 | |
| Citigroup | Buy | $50 | Jan 21, 2026 |
Questions about Wedbush and CRI
- What is Wedbush's price target for CRI?
- Wedbush's latest stated price target for Carter's Inc. (CRI) is $78, from its action on Jan 26, 2023.
- What is Wedbush's rating on CRI?
- Wedbush rates CRI Neutral, a neutral rating, as of Jan 26, 2023.
- When did Wedbush last change its view on CRI?
- On Jan 26, 2023, Wedbush downgrades to Neutral from Outperform, price target $78.
- How does Wedbush's CRI target compare with other analysts?
- Across 5 firms with a CRI price target in the last 12 months, the median target is $42.
More CRI rating histories
All Wedbush ratingsCRI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.